Accumulating evidence suggests that low levels of circulating IGF-1 and impairments of insulin/IGF-1 signaling in the brain contributed to age-dependent cognitive decline, such as Alzheimer’s disease [18,19]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.